112 related articles for article (PubMed ID: 16673595)
1. An evaluation of high-doses ketoconazole with hydrocortisone substitution in hormone-refractory prostate cancer.
Argirovic Dj
Acta Chir Iugosl; 2005; 52(4):51-4. PubMed ID: 16673595
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer.
Wilkinson S; Chodak G
Eur Urol; 2004 May; 45(5):581-4; discussion 585. PubMed ID: 15082199
[TBL] [Abstract][Full Text] [Related]
3. Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.
Harris KA; Weinberg V; Bok RA; Kakefuda M; Small EJ
J Urol; 2002 Aug; 168(2):542-5. PubMed ID: 12131305
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.
Small EJ; Baron A; Bok R
Cancer; 1997 Nov; 80(9):1755-9. PubMed ID: 9351544
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore.
Ngo LS; Yeo A; Wong AS; Tay MH
Ann Acad Med Singap; 2007 Oct; 36(10):811-4. PubMed ID: 17987231
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.
Ellerhorst JA; Tu SM; Amato RJ; Finn L; Millikan RE; Pagliaro LC; Jackson A; Logothetis CJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2371-6. PubMed ID: 9815636
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome for men with androgen independent prostate cancer treated with ketoconazole and hydrocortisone.
Scholz M; Jennrich R; Strum S; Brosman S; Johnson H; Lam R
J Urol; 2005 Jun; 173(6):1947-52. PubMed ID: 15879788
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients.
Lo EN; Beckett LA; Pan CX; Robles D; Suga JM; Sands JM; Lara PN
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):144-8. PubMed ID: 25667107
[TBL] [Abstract][Full Text] [Related]
9. Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.
Nakabayashi M; Xie W; Regan MM; Jackman DM; Kantoff PW; Oh WK
Cancer; 2006 Sep; 107(5):975-81. PubMed ID: 16862573
[TBL] [Abstract][Full Text] [Related]
10. Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
Small EJ; Halabi S; Dawson NA; Stadler WM; Rini BI; Picus J; Gable P; Torti FM; Kaplan E; Vogelzang NJ
J Clin Oncol; 2004 Mar; 22(6):1025-33. PubMed ID: 15020604
[TBL] [Abstract][Full Text] [Related]
11. Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), Intergroup/Clinical Trials Support Unit study.
Walczak JR; Carducci MA;
Urology; 2003 Dec; 62 Suppl 1():141-6. PubMed ID: 14747052
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.
Ryan CJ; Weinberg V; Rosenberg J; Fong L; Lin A; Kim J; Small EJ
J Urol; 2007 Dec; 178(6):2372-6; discussion 2377. PubMed ID: 17936834
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
[TBL] [Abstract][Full Text] [Related]
14. Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.
Nakabayashi M; Oh WK; Jacobus S; Regan MM; Taplin ME; Kantoff PW; Rosenberg JE
BJU Int; 2010 May; 105(10):1392-6. PubMed ID: 19863532
[TBL] [Abstract][Full Text] [Related]
15. Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.
Small EJ; Baron AD; Fippin L; Apodaca D
J Urol; 1997 Apr; 157(4):1204-7. PubMed ID: 9120902
[TBL] [Abstract][Full Text] [Related]
16. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
17. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
Eklund J; Kozloff M; Vlamakis J; Starr A; Mariott M; Gallot L; Jovanovic B; Schilder L; Robin E; Pins M; Bergan RC
Cancer; 2006 Jun; 106(11):2459-65. PubMed ID: 16615097
[TBL] [Abstract][Full Text] [Related]
19. A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone.
Akerley W; Butera J; Wehbe T; Noto R; Stein B; Safran H; Cummings F; Sambandam S; Maynard J; Di Rienzo G; Leone L
Cancer; 2002 Mar; 94(6):1654-60. PubMed ID: 11920525
[TBL] [Abstract][Full Text] [Related]
20. Does failure of single hormone therapy delineate hormone refractoriness for prostate cancer?
Kotwal S; Whelan P
Scand J Urol Nephrol; 2008; 42(2):116-20. PubMed ID: 17907049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
